Real-World Safety Profile of Generic Palbociclib in Hormone Receptor–Positive, HER2-Negative Metastatic Breast Cancer: A Prospective Observational Study in Iraq”. Journal of Cancer Research Updates, [S. l.], v. 15, n. 1, p. 150–155, 2026. DOI: 10.30683/1929-2279.2026.15.13. Disponível em: https://www.neoplasiaresearch.com/index.php/jcru/article/view/960. Acesso em: 10 jun. 2026.